de Vries-Bouwstra, J K <br/><br/>
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.  [electronic resource] 

 -  Arthritis and rheumatism  May 2008 
 - 1293-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.23439  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--blood<br/>Autoantibodies--blood<br/>Disease Progression<br/>Female<br/>HLA-DR Antigens--blood<br/>HLA-DRB1 Chains<br/>Humans<br/>Infliximab<br/>Male<br/>Membrane Transport Proteins--immunology<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Mitochondrial Membrane Transport Proteins<br/>Mitochondrial Proteins--immunology<br/>Rheumatoid Factor--blood<br/>Sulfasalazine--therapeutic use